Arch Therapeutics OTC Stock Target Price and Analyst Consensus

ARTH Stock  USD 1.82  0.12  6.19%   
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Arch Therapeutics price targets

Arch Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Arch Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Arch Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the OTC Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the OTC Stock's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Arch Therapeutics' stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Arch Therapeutics Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any OTC Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Arch Therapeutics is a key component of Arch Therapeutics valuation and have some predictive power on the future returns of a Arch Therapeutics.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Arch Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.091.8210.49
Details
Intrinsic
Valuation
LowRealHigh
0.091.7510.42
Details
Naive
Forecast
LowNextHigh
0.042.0710.74
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1.751.861.97
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Arch Therapeutics. Your research has to be compared to or analyzed against Arch Therapeutics' peers to derive any actionable benefits. When done correctly, Arch Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Arch Therapeutics.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Investor Favorites Idea
Investor Favorites
Invested few shares
Momentum Idea
Momentum
Invested a lot of shares
Hedge Favorites Idea
Hedge Favorites
Invested over 100 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Banking Idea
Banking
Invested over 40 shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
Check out Macroaxis Advice on Arch Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Complementary Tools for Arch OTC Stock analysis

When running Arch Therapeutics' price analysis, check to measure Arch Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arch Therapeutics is operating at the current time. Most of Arch Therapeutics' value examination focuses on studying past and present price action to predict the probability of Arch Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arch Therapeutics' price. Additionally, you may evaluate how the addition of Arch Therapeutics to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
The data published in Arch Therapeutics' official financial statements usually reflect Arch Therapeutics' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Arch Therapeutics. For example, before you start analyzing numbers published by Arch accountants, it's critical to develop an understanding of what Arch Therapeutics' liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of Arch Therapeutics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Arch Therapeutics' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Arch Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Arch Therapeutics. Please utilize our Beneish M Score to check the likelihood of Arch Therapeutics' management manipulating its earnings.